Pacific Health Care Organization, Inc. (PFHO)
OTCMKTS · Delayed Price · Currency is USD
0.8500
0.00 (0.00%)
At close: Jun 25, 2026
PFHO Market Cap
PFHO has a market cap or net worth of $10.88 million as of June 26, 2026. Its market cap has increased by 13.33% in one year.
Market Cap
10.88M
Enterprise Value
-1.65M
Revenue
6.39M
Ranking
n/a
PE Ratio
8.44
Stock Price
$0.85
Market Cap Chart
Since April 20, 2004, PFHO's market cap has increased from 2.47M to 10.88M, an increase of 341.30%. That is a compound annual growth rate of 6.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 25, 2026 | 10.88M | -34.62% |
| Dec 31, 2025 | 16.64M | 80.68% |
| Dec 31, 2024 | 9.21M | 1.34% |
| Dec 29, 2023 | 9.09M | -6.58% |
| Dec 27, 2022 | 9.73M | -20.01% |
| Dec 31, 2021 | 12.16M | -4.99% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Glass House Brands | 1.08B |
| Veradigm | 555.85M |
| Silence Therapeutics | 478.95M |
| Nika Pharmaceuticals | 466.95M |
| VitaNova Life Sciences | 11.51M |
| ALR Technologies SG | 11.30M |
| Nymox Pharmaceutical | 11.22M |
| Adaptimmune Therapeutics | 10.31M |